ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
© The Author(s) 2018. Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases and is characterized by high chemoresistance, leading to the lack of effective therapeutic approaches and grim prognosis. Despite increasing understanding of the mechanisms of chemoresistance in canc...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
Baishideng BioMed Scientific Co., Ltd
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/72542 |